Adrucil (Teva Parenteral Medicines, Inc.)
Welcome to the PulseAid listing for the Adrucil drug offered from Teva Parenteral Medicines, Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Teva Parenteral Medicines, Inc. |
| NON-PROPRIETARY NAME: | Fluorouracil |
| SUBSTANCE NAME: | FLUOROURACIL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2003-10-01 |
| END MARKETING DATE: | 0000-00-00 |
Adrucil HUMAN PRESCRIPTION DRUG Details:
| Item Description | Adrucil from Teva Parenteral Medicines, Inc. |
| LABELER NAME: | Teva Parenteral Medicines, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/mL) |
| START MARKETING DATE: | 2003-10-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0703-3015_45d40871-0880-4995-83a4-14355bb7833f |
| PRODUCT NDC: | 0703-3015 |
| APPLICATION NUMBER: | ANDA040333 |
Other FLUOROURACIL Pharmaceutical Manufacturers / Labelers:
